Rufigallol attenuates splenic damage caused by STZ by targeting oxidative stress, inflammation, and the apoptosis pathway.
- DOI
- 10.1007/s13205-026-05047-9
- Published
- 2026 Oct
- Container
- 3 Biotech
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13205-026-05047-9,
title = {Rufigallol attenuates splenic damage caused by STZ by targeting oxidative stress, inflammation, and the apoptosis pathway.},
author = {Omer AB and Afzal M and Rafeeq M and Murad HAS and Alzarea SI and Sayyed N and Kazmi I and Al-Abbasi FA},
year = {2026},
journal = {3 Biotech},
doi = {10.1007/s13205-026-05047-9},
url = {https://doi.org/10.1007/s13205-026-05047-9}
}RIS
TY - JOUR TI - Rufigallol attenuates splenic damage caused by STZ by targeting oxidative stress, inflammation, and the apoptosis pathway. AU - Omer AB AU - Afzal M AU - Rafeeq M AU - Murad HAS AU - Alzarea SI AU - Sayyed N AU - Kazmi I AU - Al-Abbasi FA PY - 2026 JO - 3 Biotech DO - 10.1007/s13205-026-05047-9 UR - https://doi.org/10.1007/s13205-026-05047-9 ER -
APA
AB, O., M, A., M, R., HAS, M., SI, A., N, S., I, K., & FA, A. (2026). Rufigallol attenuates splenic damage caused by STZ by targeting oxidative stress, inflammation, and the apoptosis pathway.. 3 Biotech. https://doi.org/10.1007/s13205-026-05047-9
Source records
- pubmed · retrieved 2026-09-25T17:04:09.135Z